HPV Testing Market is Progressing Towards a Strong Growth by 2026


Rising instances of cancer, also referred to as malignant tumor or malignant neoplasm, has spawned a booming cancer diagnostic market worldwide. This has filliped HPV (Human Papilloma Virus) testing market, which is one of the most effective means of detecting cancer, especially cervical cancer. HPV can cause cervical dysplasia and cervical dysplasia, which in turn can result in cervical cancer. HPV can also lead to rectal, oral, and penile cancer. Such HPV cancers can be thwarted with HPV vaccine.


However, almost half of women worldwide still refuse to take the life-saving three-dose vaccine. Lack of awareness, especially in developing and underdeveloped countries is one of the primary reasons behind it. But, there has been a few developments for women, wanting a screening that is expected to propel the market in the forthcoming years. An interim guidance released by the Society for Gynecologic Oncology and American Society for Colposcopy and Cervical Pathology in 2015, said HPV tests could replace Pap tests for women as young as 25.


Previous guidelines did not recommend the test for women under 30. Both tests study cells gathered from the cervix. In a Pap test, those cells are examined under a microscope for abnormalities. An HPV test looks for the presence of human papillomavirus, particularly two types that are most likely to cause cancer. The use of an HPV test in place of a Pap test, however, may take years to change the way physicians screen for cervical cancer.

Global HPV Testing Market: Trends and Opportunities : Rising instances of cervical and vaginal cancer is one of the primary reasons driving growth in the market. Cervical cancer is caused by sexually-transmissible genital virus, known as HPV. In chronic HPV infections, the pre-malignant lesions or abnormal cell growths that have been formed in the reproductive tract, grow into the progressive, malignant form of cervical cancer. The HPV and Pap test help in early detection of cervical cancer, which facilitates timely intervention at an early stage in women.


As per CDC, 16 out of 100,000 women are expected to have cervical cancer every year. It is the third-most commonly occurring cancer in women worldwide and claims lives at an alarming rate.
This, along with technological breakthroughs brought about by prominent players in the market have led to the growth in the market.

Global HPV Testing Market: Region-wise Outlook

North America has been the largest market in terms of revenue not just because of increased cases of cervical cancer in the nation, but also because of rising awareness among women resulting from government initiatives. In January 2016, for example, UAB Comprehensive Cancer Centre, in collaboration with other cancer centers in the U.S., carried out awareness programs about HPV vaccine that helps prevent many forms of cancer. Liberal funding for research studies in this direction has also led to breakthrough discoveries and innovations, which are expected to increase takers for the HPV vaccine.


Asia Pacific market is also predicted to expand rapidly in the forecast period owing to high instances of communicable diseases in the developing economies such as India. The increasing number of government awareness programs that promote the benefits of early cancer screening is further expected to propel the market growth in the coming years

Companies Mentioned in the Research Report:

The prominent players in HPV testing are Abbott, AMDL, AdnaGen, Becton Dickinson, Ambrilia Biopharma, Decode, Cepheid, Roche, Correlogic Systems, Wallac, Dako, and Diadexus

Comments

Post a Comment

Popular posts from this blog

Head Guards Market is Expected to Witness a Steady Growth by 2028

Market Overview Safety equipment plays an important role in protecting sports enthusiasts from various injuries. Head guard is the key protection equipment widely used in games like boxing, baseball and rugby. This equipment has gained traction among athletes from amateur to professional players in both, national and international competitions. Rising number of national and international sports competitions globally, the demand for head guards has surged, which will in turn increase the volume of head guard sells from retail outlets to the company online sales channel. Many sports associations such as World Rugby, International Baseball Federation and World Boxing Association have necessitated the use of head guards for players in sports matches. In baseball alone, there are over 35 million players at different levels, and the U.S. houses close to 14 million amateur and professional players. This massive number of participants in baseball creates a significant customer base for h...
Read more

Die Cut Box Market to Witness an Outstanding Growth by 2028

Die Cut Box Marke t: Overview Die cut box is an innovative packaging solution for multiple end-use sectors. Growing need for fast moving consumer goods, ingenious packaging formats from design, and size perspective,  die cut box continues to offer an advantageous edge in product positioning. Die cut box allows the leading brands and manufacturers to integrate novel design elements, which in turn assures a higher threshold of customer acquisition viz.a.viz. effective branding and marketing. Besides industry specific drivers and trends, macroeconomic factors will also continue to influence demand for the die cut box across industries. Such factor include but aren’t limited to per capita disposable income, food retail sector growth, modern retail establishment growth etc. Outpacing growth in the e-commerce sector has gained traction for the corrugated packaging industry. Die cut box cost wouldn’t be a big burn to the pocket of die cut box manufacturers despite the re-usability of ...
Read more

Gynaecological Cancer Drugs Market Accounting US$ 41,855.8 million by 2026

The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026. Treatment of cancer is being increasingly focused on be leading pharmaceutical companies, researchers, healthcare institutes and governments of various countries. With increasing number of research and development activities in cancer treatment, especially in gynaecological cancer treatment, new treatments are reaching an increasing number of physicians faster than ever. Also, availability of advanced treatment options and drugs has resulted in the decline in cancer mortality rate across major developed countries. However, the scenario is not same in the developing nations. This is due to the high cost of cancer treatment and lack of availability of new treatments. Gynaecologi...
Read more